Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ascend’s EstroGel Promotion Misrepresents Efficacy Compared To Other Products, US FDA Says

Executive Summary

Professional sell sheet falsely suggests estradiol gel contains lowest effective dose of estrogen compared to other estrogen products, OPDP says in fourth “untitled” letter of 2018.


Advertisement

Related Content

Advertising Enforcement: US FDA Content To Let Competitors 'Duke It Out,' Woodcock Says
US FDA Reprimands Arog Pharmaceuticals For Promo Of Investigational AML Drug
FDA Rx Drug Promotion Rules Extend To Online Interviews, Pfizer Learns
Xtampza ER Warnings Can't Be Hidden Behind Table And Chairs, US FDA Tells Collegium
Don't Try This At Home: Zazzle-Created EstroGel Promo Card Fizzles With FDA

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS123764

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel